Related Experiment Video
Updated: Jun 22, 2026
11:31
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Treating autoimmune disease by targeting CD8(+) T suppressor cells
Christine Konya1, Jorg J Goronzy, Cornelia M Weyand
1Emory University School of Medicine, Kathleen B. and Mason I. Lowance Center for Human Immunology and Rheumatology, Atlanta, GA 30322, USA.
Expert Opinion on Biological Therapy
|June 16, 2009
Summary
Targeting CD8 T suppressor (Ts) cells offers a novel strategy for autoimmune disease. These cells can specifically downregulate harmful immune responses while preserving protective immunity, potentially reducing side effects.
Area of Science:
- Immunology
- Autoimmune Diseases
- Cellular Immunology
Background:
- Current autoimmune disease treatments rely on broad immunosuppression, leading to significant side effects like infection and malignancy.
- Developing antigen-specific therapies is crucial to downregulate pathogenic immune responses while maintaining essential protective immunity.
Purpose of the Study:
- To explore the potential of targeting CD8 T suppressor (Ts) cells for antigen-specific immunomodulation in autoimmune diseases.
- To investigate CD8 Ts cells as a therapeutic strategy to disrupt host-injurious immune responses.
Main Methods:
- The study focuses on the physiological regulatory mechanisms of CD8 T suppressor (Ts) cells.
- Investigating how CD8 Ts cells inhibit other T cells or modulate antigen-presenting cells to dampen immune amplification.
Main Results:
- CD8 T suppressor (Ts) cells show promise in disrupting harmful immune responses in a targeted manner.
- Emerging evidence indicates the existence of multiple subsets of CD8 Ts cells with varying functions.
Conclusions:
- CD8 T suppressor (Ts) cells represent a promising avenue for developing targeted therapies for autoimmune diseases.
- Further research into the molecular mechanisms and therapeutic applications of CD8 Ts cells is warranted.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:40Cell-mediated Immune Responses
Overview
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...